
|
|
B Cells In Autoimmunity and Multiple SclerosisScientific ProgramThursday, November 29, 2007
8:00 am Registration
9:00 am Introductory Remarks David Scott
SESSION I - B Cells as Effectors and Regulators in Autoimmunity
9:20 am Multiple Sclerosis: to B or not to B Amit Bar-Or
10:00 am Antigen Editing by B Cells in Autoimmunity Mark Mamula
10:40 am Break
11:00 am The Role of B Cells in Regulating CNS Inflammation Bonnie Dittel
11:40 am Lunch
SESSION II - B cells as APC in MS/EAE
1:00 pm T-B Cell Interactions in Spontaneous EAE Hartmut Wekerle
1:40 pm Gene Therapy for MS: Role of B Cells David Scott
2:20 pm Break
2:40 pm Differential Effects of Anti-CD20 B Cell Depletion in Treatment of CNS Autoimmunity Scott Zamvil
SESSION III- Antigen Presentation in the CNS
3:20 pm The Inflamed CNS as a Neo-Lymphoid Organ: Functional Identification of Dendritic Cell Subsets Promoting and Regulating Epitope Spreading Stephen Miller
4:00 pm Pathologic Relevance of Ectopic B Cell Follicles in the Multiple Sclerosis Brain Franchesca Aloisi
4:40 pm How B Cells Shape the Inflammatory Response in EAE Joan Goverman
5:20 pm Poster Reception
Friday, November 30, 2007
7:00 - 8:00 am Breakfast
8:00 am Opening Remarks Joan Goverman
SESSION IV - Pathogenic Role of Antibody in MS/EAE
8:10 am Pathogenic Autoantibodies in MS: from Demyelination to Axonal Injury Chris Linington
8:50 am Effector Function of Demyelinating Abs: How Do Abs Damage the Brain? Buchard Becher
9:30 am Differential Recognition of MOG by Pathogenic and Nonpathogenic Antibodies Nancy Ruddle
10:10 am Break
SESSION V - B Cell Footprints in MS
10:30 am B cells and Autoantibodies in Pediatric MS Kai Wucherpfennig
11:10 am Immunopathogenesis of MS and Related Disorders Claudia Lucchinetti
11:50 am Characterization of B cells in MS Plaque Tissue David Hafler
12:30 pm Lunch
SESSION VI - Lymphocyte Trafficking
1:30 pm A New View of Immune Surveillance in the CNS Richard Ransohoff
2:10 pm Imaging Adaptive Immune Responses in Living Animals Ulrich von Adrian
2:50 pm Plasma Blast Regulation During Virus-induced Demyelination Cornelia Bergmann
3:30 pm Break
SESSION VII - B Cells in MS Therapies
3:50 pm CD20 Depletion in Relapsing Remitting MS: Confirmation of Activity in Phase I/II Craig Smith
4:30 pm Specific Downregulation of Immune Responses as a Treatment Strategy for T cell-mediated Autoimmune Diseases Using Genetically Modified B cells Yacov Ron
5:10 pm Rituximab Use in Relapsing MS Patients Who are Sub-optimally Treated with Standard Therapies Anne Cross
5:50 pm Presentation of National Multiple Sclerosis Society Poster Awards and Closing Remarks
6:00 pm Adjourn |
|